JP2016501882A5 - - Google Patents

Download PDF

Info

Publication number
JP2016501882A5
JP2016501882A5 JP2015545854A JP2015545854A JP2016501882A5 JP 2016501882 A5 JP2016501882 A5 JP 2016501882A5 JP 2015545854 A JP2015545854 A JP 2015545854A JP 2015545854 A JP2015545854 A JP 2015545854A JP 2016501882 A5 JP2016501882 A5 JP 2016501882A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
hydrogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015545854A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016501882A (ja
JP6256771B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/073424 external-priority patent/WO2014089364A1/en
Publication of JP2016501882A publication Critical patent/JP2016501882A/ja
Publication of JP2016501882A5 publication Critical patent/JP2016501882A5/ja
Application granted granted Critical
Publication of JP6256771B2 publication Critical patent/JP6256771B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015545854A 2012-12-06 2013-12-05 ヒストンデメチラーゼ阻害剤 Expired - Fee Related JP6256771B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261734330P 2012-12-06 2012-12-06
US61/734,330 2012-12-06
US201361784414P 2013-03-14 2013-03-14
US61/784,414 2013-03-14
PCT/US2013/073424 WO2014089364A1 (en) 2012-12-06 2013-12-05 Histone demethylase inhibitors

Publications (3)

Publication Number Publication Date
JP2016501882A JP2016501882A (ja) 2016-01-21
JP2016501882A5 true JP2016501882A5 (enExample) 2016-12-01
JP6256771B2 JP6256771B2 (ja) 2018-01-10

Family

ID=50884011

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015545854A Expired - Fee Related JP6256771B2 (ja) 2012-12-06 2013-12-05 ヒストンデメチラーゼ阻害剤

Country Status (7)

Country Link
US (7) US9604961B2 (enExample)
EP (2) EP3763367A1 (enExample)
JP (1) JP6256771B2 (enExample)
CA (1) CA2894399A1 (enExample)
ES (1) ES2834959T3 (enExample)
MX (1) MX2015007205A (enExample)
WO (1) WO2014089364A1 (enExample)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE033380T2 (en) 2012-10-02 2017-11-28 Gilead Sciences Inc Inhibitors of histone demethylases
US9604961B2 (en) 2012-12-06 2017-03-28 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
MX2015011097A (es) 2013-02-27 2016-03-09 Epitherapeutics Aps Inhibidores de histona desmetilasas.
JP2017066030A (ja) * 2014-02-04 2017-04-06 アグロカネショウ株式会社 新規なピラゾール誘導体およびこれを有効成分とする農園芸用薬剤
KR102359214B1 (ko) 2014-04-04 2022-02-07 델 마 파마슈티컬스 폐의 비소세포 암종 및 난소암을 치료하기 위한 디안하이드로갈락티톨 및 이의 유사체 또는 유도체
AR100997A1 (es) * 2014-06-25 2016-11-16 Quanticel Pharmaceuticals Inc Derivados de piridina como inhibidores de histona demetilasa
TR201909606T4 (tr) 2014-07-31 2019-07-22 Basf Se Pi̇razollari hazirlamak i̇çi̇n i̇şlem
CN107074846B (zh) 2014-08-12 2020-05-19 先正达参股股份有限公司 具有含硫取代基的杀有害生物活性杂环衍生物
EA201790154A1 (ru) 2014-08-27 2017-08-31 Джилид Сайэнс, Инк. Соединения и способы для ингибирования гистоновых деметилаз
US9896436B2 (en) 2014-09-16 2018-02-20 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
CN107073006A (zh) * 2014-09-16 2017-08-18 赛尔基因昆蒂赛尔研究公司 组蛋白脱甲基酶抑制剂
BR112017023935B1 (pt) 2015-05-11 2020-07-07 Basf Se processo para a preparação de um composto
DK3411360T3 (da) 2016-02-02 2020-06-08 Basf Se Fremgangsmåde til katalytisk hydrogenering til fremstilling af pyrazoler
US20190055212A1 (en) * 2016-02-16 2019-02-21 Stephen Gwaltney Histone demethylase inhibitors
EP3436445B1 (en) * 2016-03-15 2023-09-06 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
US10150754B2 (en) 2016-04-19 2018-12-11 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
WO2017198785A1 (en) * 2016-05-18 2017-11-23 Ieo - Istituto Europeo Di Oncologia S.R.L. Oxime derivatives useful as inhibitors of histone demethylase kdm4c
CN118178652A (zh) 2016-05-27 2024-06-14 吉利德科学公司 使用ns5a、ns5b或ns3抑制剂治疗乙型肝炎病毒感染的方法
BR102017010009A2 (pt) 2016-05-27 2017-12-12 Gilead Sciences, Inc. Compounds for the treatment of hepatitis b virus infection
WO2017207813A1 (en) 2016-06-03 2017-12-07 Oryzon Genomics, S.A. Heteroaryl-carboxylic acids as histone demethylase inhibitors
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
MA46093A (fr) 2016-09-02 2021-05-19 Gilead Sciences Inc Composés modulateurs du recepteur de type toll
US10640499B2 (en) 2016-09-02 2020-05-05 Gilead Sciences, Inc. Toll like receptor modulator compounds
FI3526323T3 (fi) 2016-10-14 2023-06-06 Prec Biosciences Inc Hepatiitti B -viruksen genomissa oleville tunnistussekvensseille spesifisiä muokattuja meganukleaaseja
TW202510891A (zh) 2017-01-31 2025-03-16 美商基利科學股份有限公司 替諾福韋埃拉酚胺(tenofovir alafenamide)之晶型
JOP20180008A1 (ar) 2017-02-02 2019-01-30 Gilead Sciences Inc مركبات لعلاج إصابة بعدوى فيروس الالتهاب الكبدي b
JOP20180040A1 (ar) 2017-04-20 2019-01-30 Gilead Sciences Inc مثبطات pd-1/pd-l1
WO2018219478A1 (en) 2017-06-02 2018-12-06 Oryzon Genomics, S.A. Heteroaryl-carboxamides as histone demethylase inhibitors
CA3084569A1 (en) 2017-12-20 2019-06-27 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
KR102492115B1 (ko) 2017-12-20 2023-01-27 인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. Sting 어댑터 단백질을 활성화하는 포스포네이트 결합을 가진 2'3' 사이클릭 다이뉴클레오티드
EP4227302A1 (en) 2018-02-13 2023-08-16 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
US10836769B2 (en) 2018-02-26 2020-11-17 Gilead Sciences, Inc. Substituted pyrrolizine compounds and uses thereof
US10870691B2 (en) 2018-04-05 2020-12-22 Gilead Sciences, Inc. Antibodies and fragments thereof that bind hepatitis B virus protein X
TWI818007B (zh) 2018-04-06 2023-10-11 捷克科學院有機化學與生物化學研究所 2'3'-環二核苷酸
TWI833744B (zh) 2018-04-06 2024-03-01 捷克科學院有機化學與生物化學研究所 3'3'-環二核苷酸
TW202005654A (zh) 2018-04-06 2020-02-01 捷克科學院有機化學與生物化學研究所 2,2,─環二核苷酸
US11142750B2 (en) 2018-04-12 2021-10-12 Precision Biosciences, Inc. Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
US10899735B2 (en) 2018-04-19 2021-01-26 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
TW202014193A (zh) 2018-05-03 2020-04-16 捷克科學院有機化學與生物化學研究所 包含碳環核苷酸之2’3’-環二核苷酸
UA126421C2 (uk) 2018-07-13 2022-09-28 Гіліад Сайєнсіз, Інк. Інгібітори pd-1/pd-l1
WO2020028097A1 (en) 2018-08-01 2020-02-06 Gilead Sciences, Inc. Solid forms of (r)-11-(methoxymethyl)-12-(3-methoxypropoxy)-3,3-dimethyl-8-0x0-2,3,8,13b-tetrahydro-1h-pyrido[2,1-a]pyrrolo[1,2-c] phthalazine-7-c arboxylic acid
AU2019366355B2 (en) 2018-10-24 2022-10-13 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
HRP20240541T1 (hr) 2018-10-31 2024-07-05 Gilead Sciences, Inc. Supstituirani spojevi 6-azabenzimidazola kao inhibitori hpk1
WO2020092528A1 (en) 2018-10-31 2020-05-07 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
WO2020178768A1 (en) 2019-03-07 2020-09-10 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
US12318403B2 (en) 2019-03-07 2025-06-03 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 2′3′-cyclic dinucleotides and prodrugs thereof
EP3935066A1 (en) 2019-03-07 2022-01-12 Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. 3'3'-cyclic dinucleotides and prodrugs thereof
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
EP3972695A1 (en) 2019-05-23 2022-03-30 Gilead Sciences, Inc. Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
JP7237311B2 (ja) * 2019-06-06 2023-03-13 京都府公立大学法人 化合物、医薬組成物、kdm5c阻害剤及び抗うつ剤
CN110128347A (zh) * 2019-06-17 2019-08-16 韶远科技(上海)有限公司 一种1-甲基-1h-吲唑-6-甲酸的合成方法
BR112021026376A2 (pt) 2019-06-25 2022-05-10 Gilead Sciences Inc Proteínas de fusão flt3l-fc e métodos de uso
US20220257619A1 (en) 2019-07-18 2022-08-18 Gilead Sciences, Inc. Long-acting formulations of tenofovir alafenamide
WO2021034804A1 (en) 2019-08-19 2021-02-25 Gilead Sciences, Inc. Pharmaceutical formulations of tenofovir alafenamide
JP7398556B2 (ja) 2019-09-30 2023-12-14 ギリアード サイエンシーズ, インコーポレイテッド Hbvワクチン及びhbvを治療する方法
WO2021113765A1 (en) 2019-12-06 2021-06-10 Precision Biosciences, Inc. Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome
USD1000624S1 (en) 2019-12-27 2023-10-03 Thomas Nichols Personal care device with camera
WO2021188959A1 (en) 2020-03-20 2021-09-23 Gilead Sciences, Inc. Prodrugs of 4'-c-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same
CN115605467B (zh) * 2020-03-20 2025-06-13 阿克比治疗有限公司 Phd抑制剂化合物、组合物和其用途
BR112022018877A2 (pt) * 2020-03-20 2022-11-29 Akebia Therapeutics Inc Compostos, composição farmacêutica e método para tratar uma doença mediada por atividade de phd
MX2022011392A (es) * 2020-03-20 2022-12-15 Akebia Therapeutics Inc Compuestos inhibidores de phd, composiciones y uso.
HRP20251374T1 (hr) 2020-08-07 2025-12-19 Gilead Sciences, Inc. Prolijekovi nukleotidnih analoga fosfonamida i njihova farmaceutska uporaba
EP4219453A4 (en) * 2020-09-28 2024-10-09 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. PYRAZOLE COMPOUND AND ITS PREPARATION METHOD AND ITS USE
TW202406932A (zh) 2020-10-22 2024-02-16 美商基利科學股份有限公司 介白素2-Fc融合蛋白及使用方法
WO2022241134A1 (en) 2021-05-13 2022-11-17 Gilead Sciences, Inc. COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS
AU2022297367B2 (en) 2021-06-23 2025-04-10 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
CN117377671A (zh) 2021-06-23 2024-01-09 吉利德科学公司 二酰基甘油激酶调节化合物
IL309378A (en) 2021-06-23 2024-02-01 Gilead Sciences Inc Diacylglyercol kinase modulating compounds
CA3222277A1 (en) 2021-06-23 2022-12-29 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
WO2024100791A1 (ja) * 2022-11-09 2024-05-16 株式会社日本ファインケム 1-アルキル-5-ヒドロキシピラゾールの製造方法
WO2025240244A1 (en) 2024-05-13 2025-11-20 Gilead Sciences, Inc. Combination therapies comprising bulevirtide and lonafarnib for use in the treatment of hepatitis d virus infection
WO2025240242A1 (en) 2024-05-13 2025-11-20 Gilead Sciences, Inc. Combination therapies with ribavirin
US20250345389A1 (en) 2024-05-13 2025-11-13 Gilead Sciences, Inc. Combination therapies
WO2025240246A1 (en) 2024-05-13 2025-11-20 Gilead Sciences, Inc. Combination therapies with ribavirin

Family Cites Families (138)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI68369C (fi) 1983-03-01 1985-09-10 Waertsilae Oy Ab Bestrykningsanordning
US4824859A (en) 1983-05-21 1989-04-25 Fisons Plc. Pyrazoline compounds compositions and use
FI855180L (fi) 1985-01-18 1986-07-19 Nissan Chemical Ind Ltd Pyrazolsulfonamidderivat, foerfarande foer dess framstaellande och det innehaollande ograesgift.
US4699647A (en) 1985-05-30 1987-10-13 E. I. Du Pont De Nemours And Company Herbicidal sulfonamides
DE3528477A1 (de) 1985-08-08 1987-02-19 Bayer Ag 1-aryl-pyrazole
DE3538731A1 (de) 1985-10-31 1987-05-07 Bayer Ag 1-aryl-4-nitro-pyrazole
DE3539844A1 (de) 1985-11-09 1987-05-14 Bayer Ag Substituierte 5-amino-1-aryl-pyrazole
DE3543035A1 (de) 1985-12-05 1987-06-11 Bayer Ag 5-fluoracylamino-4-nitro-1-aryl-pyrazole
DE3543034A1 (de) 1985-12-05 1987-06-11 Bayer Ag 5-perfluoracylamino-4-nitro-1-aryl-pyrazol-salze
DE3600950A1 (de) 1986-01-15 1987-07-16 Bayer Ag 5-acylamido-1-aryl-pyrazole
DE3609542A1 (de) 1986-03-21 1987-10-01 Bayer Ag 5-acylamino-pyrazol-derivate
DE3625686A1 (de) 1986-07-30 1988-02-04 Bayer Ag 4-cyano(nitro)-5-oxy(thio)-pyrazol-derivate
DE3628892A1 (de) 1986-08-26 1988-03-10 Bayer Ag Substituierte 1-aryl-3-tert.-butyl-pyrazole
DE3631003A1 (de) 1986-09-12 1988-03-24 Bayer Ag Verfahren zur herstellung von 4-substituierten 1-aryl-5-amino-pyrazolen
DE3637710A1 (de) 1986-11-05 1988-05-11 Bayer Ag 5-acylamino-pyrazol-derivate
DE3707551A1 (de) 1987-03-10 1988-09-22 Bayer Ag Substituierte 1-arylpyrazole
DE3721868A1 (de) 1987-07-02 1989-01-12 Bayer Ag 1-arylpyrazole
DE3911556A1 (de) 1989-04-08 1990-10-11 Bayer Ag Substituierte 1-arylpyrazole
DE4023488A1 (de) * 1990-07-24 1992-01-30 Bayer Ag 1-(pyri(mi)dyl-(2)) -5-hydroxy-pyrazol-mikrobizide
US5298368A (en) 1991-04-23 1994-03-29 Eastman Kodak Company Photographic coupler compositions and methods for reducing continued coupling
US5292844A (en) 1991-05-22 1994-03-08 Minnesota Mining And Manufacturing Company Vinyl acetate modified suspension polymer beads, adhesives made therefrom and a method of making
US5262284A (en) 1991-07-15 1993-11-16 Eastman Kodak Company Arylidene pyrazolone coupler
DE4126244A1 (de) 1991-08-08 1993-02-11 Bayer Ag Massefaerben von kunststoffen
US5250405A (en) 1991-08-29 1993-10-05 Eastman Kodak Company Color photographic materials including magenta coupler, inhibitor-releasing coupler and carbonamide compound, and methods
US5200309A (en) 1991-08-29 1993-04-06 Eastman Kodak Company Color photographic materials including magenta coupler, carbonamide compound and aniline or amine compound, and methods
US5376519A (en) 1992-04-23 1994-12-27 Eastman Kodak Company Photographic material containing a coupler composition comprising magenta coupler, phenolic solvent, and at least one aniline or amine
US5340707A (en) 1992-09-16 1994-08-23 Konica Corporation Silver halide photographic light-sensitive material
WO1994022853A1 (en) 1993-03-26 1994-10-13 Shell Internationale Research Maatschappij B.V. Herbicidal 1-heteroaryl pyrazolidin-3,5-diones
US5389504A (en) 1993-06-24 1995-02-14 Eastman Kodak Company Color photographic elements containing a combination of pyrazolone and pyrazoloazole couplers
DE69522513T2 (de) 1994-06-23 2002-04-11 Eastman Kodak Co., Rochester Fotographische Zwei-Äquivalent-Purpurrot-Kuppler mit die Aktivität modifizierender Ballastgruppen
EP0795548B1 (en) 1995-09-28 2002-07-03 Suntory Limited Quinazoline derivatives and use thereof
WO1998024785A1 (en) 1996-12-02 1998-06-11 Fujisawa Pharmaceutical Co., Ltd. Indole-urea derivatives with 5-ht antagonist properties
US5821043A (en) 1996-12-30 1998-10-13 Eastman Kodak Company 1,2,4-triazole-releasing pyrazolone DIR couplers
CO5060426A1 (es) 1997-03-10 2001-07-30 Rhone Poulenc Agrochimie 1-aril-3-imidiopirazoles plaguicidas
US5958662A (en) 1997-03-25 1999-09-28 Eastman Kodak Company Photographic element containing a DIR coupler
US5942381A (en) 1997-06-12 1999-08-24 Eastman Kodak Company Photographic element and process employing active, stable benzotriazole-releasing DIR couplers
US5998424A (en) 1997-06-19 1999-12-07 Dupont Pharmaceuticals Company Inhibitors of factor Xa with a neutral P1 specificity group
KR100512227B1 (ko) 1997-09-05 2005-09-05 바스프 악티엔게젤샤프트 헤테로(방향족)히드록실아민의 제조 방법
DE19804486A1 (de) 1998-02-05 1999-08-12 Basf Ag 2-(Pyrazolyloxy)-pyridin-3-ylessigsäure- Derivate, sie enthaltende Mittel und ihr
US6121271A (en) 1998-05-12 2000-09-19 American Home Products Corporation Naphtho[2,3-B]heteroar-4-yl derivatives
US6010839A (en) 1998-06-26 2000-01-04 Eastman Kodak Company Color photographic elements containing yellow-colored magenta dye-forming masking couplers
US20030191279A1 (en) 1999-08-27 2003-10-09 Goldstein Steven Wayne Urea derivatives useful as anticancer agents
US6132943A (en) 1999-10-14 2000-10-17 Eastman Kodak Company Color photographic elements containing yellow-colored magenta dye-forming masking couplers
JP2001335714A (ja) 2000-03-22 2001-12-04 Fuji Photo Film Co Ltd アゾ色素、その製造方法、インクジェット用インク、インクジェット記録方法
WO2001081333A2 (en) 2000-04-25 2001-11-01 Pharmacia Corporation Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
JP4113323B2 (ja) 2000-08-07 2008-07-09 富士フイルム株式会社 アゾ色素及びそれを含むインクジェット記録用インク、並びにインクジェット記録方法
US6710058B2 (en) 2000-11-06 2004-03-23 Bristol-Myers Squibb Pharma Company Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
JP2002167531A (ja) 2000-11-29 2002-06-11 Fuji Photo Film Co Ltd インクジェット記録用インク組成物及び画像形成方法
US6673818B2 (en) 2001-04-20 2004-01-06 Pharmacia Corporation Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
US6603000B2 (en) 2001-07-11 2003-08-05 Boehringer Ingelheim Pharmaceuticals, Inc. Synthesis for heteroarylamine compounds
TWI312274B (en) 2001-08-13 2009-07-21 Du Pont Method for controlling particular insect pests by applying anthranilamide compounds
CA2454298A1 (en) 2001-08-13 2003-02-27 Gary David Annis Substituted 1h-dihydropyrazoles, their preparation and use
TWI371450B (en) 2001-08-13 2012-09-01 Du Pont Novel substituted dihydro 3-halo-1h-pyrazole-5-carboxylates,their preparation and use
ATE417829T1 (de) 2001-08-16 2009-01-15 Du Pont Substituierte anthranilamide und ihre verwendung als pesticide
SE0103644D0 (sv) 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic isoquinoline compounds
JP2005526723A (ja) 2002-02-15 2005-09-08 グラクソ グループ リミテッド バニロイド受容体モジュレーター
US7560563B2 (en) 2002-07-23 2009-07-14 Kuraray Co., Ltd. Process for producing 2-substituted pyridine derivative
TWI343376B (en) 2002-07-31 2011-06-11 Du Pont Method for preparing 3-halo-4, 5-dihydro-1h-pyrazoles
TWI326283B (en) 2002-07-31 2010-06-21 Du Pont Method for preparing fused oxazinones
PA8578101A1 (es) 2002-08-13 2004-05-07 Warner Lambert Co Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz
BR0315508A (pt) 2002-10-23 2005-08-23 Banyu Pharma Co Ltd Processo para preparação de compostos de pirazol
JP4648705B2 (ja) 2002-11-15 2011-03-09 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 新規アントラニルアミド殺虫剤
US20070066640A1 (en) 2003-01-16 2007-03-22 Emiliano Castiglioni Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists
CA2515544A1 (en) 2003-02-11 2004-08-26 Kemia Inc. Compounds for the treatment of viral infection
TWI367882B (en) 2003-03-26 2012-07-11 Du Pont Preparation and use of 2-substituted-5-oxo-3-pyrazolidinecarboxylates
ZA200508771B (en) 2003-06-12 2008-04-30 Du Pont Method for preparing fused oxazinones
WO2005023773A1 (en) 2003-09-04 2005-03-17 Pfizer Limited Process for the preparation of substituted aryl pyrazoles
GB0323585D0 (en) 2003-10-08 2003-11-12 Glaxo Group Ltd Compounds
DE102004006075A1 (de) 2003-11-14 2005-06-16 Bayer Cropscience Ag Wirkstoffkombinationen mit insektiziden Eigenschaften
DE10353281A1 (de) 2003-11-14 2005-06-16 Bayer Cropscience Ag Wirkstoffkombination mit insektiziden und akariziden Eigenschaften
DE102004021564A1 (de) 2003-11-14 2005-07-07 Bayer Cropscience Ag Wirkstoffkombinationen mit insektiziden Eigenschaften
WO2005053406A1 (de) 2003-12-04 2005-06-16 Bayer Cropscience Aktiengesellschaft Wirkstoffkombinationen mit insektiziden eigenschaften
BRPI0417315B1 (pt) 2003-12-04 2016-03-08 Bayer Cropscience Ag agente para controle de pragas animais, seu uso, processo para combater pragas animais, e processo para produção de agentes praguicidas.
DE10356550A1 (de) 2003-12-04 2005-07-07 Bayer Cropscience Ag Wirkstoffkombinationen mit insektiziden Eigenschaften
DE102004023635A1 (de) 2004-05-10 2006-04-13 Grünenthal GmbH Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate
KR101195801B1 (ko) 2004-06-18 2012-11-05 밀레니엄 파머슈티컬스 인코퍼레이티드 Xa 인자 억제제
DE102004031100A1 (de) 2004-06-28 2006-01-12 Bayer Cropscience Ag Anthranilamide
DE102004035134A1 (de) 2004-07-20 2006-02-16 Bayer Cropscience Ag Selektive Insektizide auf Basis von Halogenalkylnicotinsäurederivaten, Anthranilsäureamiden oder Phthalsäurediamiden und Safenern
CA2578122A1 (en) 2004-08-27 2006-03-02 Gpc Biotech Ag Pyrimidine derivatives
CA2583976A1 (en) 2004-10-13 2006-04-27 Ptc Therapeutics, Inc. Use of defined compounds for the manufacture of a medicament for preventing/treating diseases resulting from somatic mutations
EP1846390B1 (en) 2005-02-01 2010-03-17 Nycomed GmbH Novel 6-pyridylphenanthridines
US20080167316A1 (en) 2005-03-02 2008-07-10 Altana Pharma Ag 6-Heteroaryl-1,2,3,4,4A, 10B-Hexahydrophenanthridines as Pde4-Inhibitors for the Treatment of Inflammatory Disorders
EP1728790A1 (en) 2005-06-01 2006-12-06 Max-Delbrück-Centrum Für Molekulare Medizin Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases
BRPI0613535A2 (pt) 2005-06-02 2011-01-18 Bayer Cropscience Ag derivados de heteroarila substituìda por fenilalquila
EP1910298B1 (en) 2005-06-24 2010-01-13 Brystol-Myers Squibb Company Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
EA016139B1 (ru) 2005-07-07 2012-02-28 Басф Акциенгезельшафт N-тиоантраниламидные соединения и их применение в качестве пестицидов
WO2007131538A1 (en) 2005-07-15 2007-11-22 Laboratorios Del Dr. Esteve, S.A. Azepane- or azocane-substituted pyrazoline compounds, their preparation and use as medicaments
EP1937691A1 (en) 2005-10-21 2008-07-02 Dow Agrosciences LLC Thieno-pyrimidine compounds having fungicidal activity
US7531482B2 (en) 2005-10-21 2009-05-12 Dow Agrosciences Llc Thieno-pyrimidine compounds having fungicidal activity
AU2006316321A1 (en) 2005-11-22 2007-05-31 Merck & Co., Inc. Indole orexin receptor antagonists
CA2636314A1 (en) 2005-11-29 2007-06-07 Toray Industries, Inc. Arylmethylene urea derivative and use thereof
US7855201B2 (en) 2005-12-06 2010-12-21 Merck Sharp & Dohme. Corp. Morpholine carboxamide prokineticin receptor antagonists
DE102005059470A1 (de) 2005-12-13 2007-06-14 Bayer Cropscience Ag Insektizide Zusammensetzungen mit verbesserter Wirkung
MX2008012515A (es) 2006-03-30 2008-11-19 Ptc Therapeutics Inc Metodos para la produccion de proteina funcional a partir de adn que tiene una mutacion sin sentido y el tratamiento de trastornos asociados con la misma.
KR101325062B1 (ko) 2006-05-19 2013-11-05 삼성디스플레이 주식회사 발광 이종 핵 구리-이리듐 착체 및 이를 이용한 유기 전계발광 소자
CL2007002123A1 (es) 2006-07-21 2008-06-13 Irm Llc Compuestos derivados de heteroaril-1h-pirazol, utiles como moduladores del desarrollo y funcion de los linfocitos b.
WO2008023235A1 (en) 2006-08-25 2008-02-28 Pfizer Products Inc. Pyrazole derivatives as anti-platelet and anti-thrombotic agents
KR20090066297A (ko) 2006-10-16 2009-06-23 화이자 프로덕츠 인크. 치료용 피라졸릴 티에노피리딘
US7998995B2 (en) 2006-12-08 2011-08-16 Exelixis Patent Company Llc LXR and FXR modulators
CN101611007A (zh) 2006-12-20 2009-12-23 先灵公司 新颖的jnk抑制剂
EP1958934A1 (en) 2007-02-16 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents
WO2008106202A1 (en) 2007-02-27 2008-09-04 Housey Gerard M Theramutein modulators
JP5378988B2 (ja) 2007-04-11 2013-12-25 キッセイ薬品工業株式会社 5員環へテロ環誘導体及びその医薬用途
US8071035B2 (en) 2007-04-12 2011-12-06 Siemens Medical Solutions Usa, Inc. Microfluidic radiosynthesis system for positron emission tomography biomarkers
WO2008128335A1 (en) 2007-04-20 2008-10-30 Merck Frosst Canada Ltd. Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
EP2148868A1 (en) 2007-05-15 2010-02-03 NeuroSearch A/S Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
US7776877B2 (en) 2007-06-22 2010-08-17 Chemocentryx, Inc. N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
WO2009022171A1 (en) 2007-08-13 2009-02-19 Astrazeneca Ab Pyridinyiioxy pyridines as alk5 inhibitors
CA2705848C (en) 2007-11-21 2016-02-02 Bio-Rad Laboratories, Inc. Photoluminescent metal complexes for protein staining
AU2008336224A1 (en) 2007-12-11 2009-06-18 Merck Frosst Canada Ltd Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme A delta-9 desaturase
NZ586104A (en) 2007-12-20 2012-02-24 Astrazeneca Ab Carbamoyl compounds as dgat1 inhibitors 190
JP2011510073A (ja) 2008-01-25 2011-03-31 アリーナ ファーマシューティカルズ, インコーポレイテッド S1P1アゴニストとして作用するジヒドロ−1H−ピロロ[1,2−a]インドール−1−イルカルボン酸誘導体
CA2721060A1 (en) 2008-04-09 2009-10-15 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US20110059940A1 (en) 2008-05-08 2011-03-10 Bristol- Myers Squibb Company 2-Aryl Glycinamide Derivatives
CA2733958A1 (en) 2008-08-14 2010-02-18 Bayer Cropscience Ag Insecticidal 4-phenyl-1h-pyrazoles
GB0818907D0 (en) * 2008-10-15 2008-11-19 Isis Innovation Histone lysine demethylase inhibitors
JP2012506386A (ja) 2008-10-21 2012-03-15 メタボレックス, インコーポレイテッド アリールgpr120受容体アゴニストおよびその使用
ES2401670T3 (es) 2008-12-04 2013-04-23 F. Hoffmann-La Roche Ag Derivados de piridazinona
KR20110120320A (ko) 2009-02-11 2011-11-03 다우 아그로사이언시즈 엘엘씨 살충 조성물
US20110059962A1 (en) 2009-04-22 2011-03-10 Alekshun Michael N Transcription factor modulating compounds and methods of use thereof
US8927551B2 (en) 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
WO2011028043A2 (ko) 2009-09-02 2011-03-10 이화여자대학교 산학협력단 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물
WO2011028044A2 (ko) * 2009-09-02 2011-03-10 이화여자대학교 산학협력단 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물
US8394858B2 (en) 2009-12-03 2013-03-12 Novartis Ag Cyclohexane derivatives and uses thereof
SG10201408429UA (en) 2009-12-18 2015-02-27 Activesite Pharmaceuticals Inc Prodrugs of inhibitors of plasma kallikrein
US8598211B2 (en) 2009-12-22 2013-12-03 Abbvie Inc. Carboxamide compounds and their use as calpain inhibitors IV
US9051304B2 (en) 2009-12-22 2015-06-09 AbbVie Deutschland GmbH & Co. KG Carboxamide compounds and their use as calpain inhibitors V
EP2552214A4 (en) 2010-03-26 2013-10-16 Glaxo Group Ltd PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
JP5787977B2 (ja) 2010-04-08 2015-09-30 レスピバート・リミテツド P38mapキナーゼ阻害剤
MA34300B1 (fr) 2010-05-13 2013-06-01 Amgen Inc Composés azotés hétérocycliques convenant comme inhibiteurs de la pde10
WO2012004293A2 (de) 2010-07-08 2012-01-12 Bayer Cropscience Ag Insektizide und fungizide wirkstoffkombinationen
EP2635566B1 (en) 2010-11-01 2018-05-16 Boehringer Ingelheim International GmbH Benzimidazole inhibitors of leukotriene production
WO2012063207A1 (en) 2010-11-10 2012-05-18 Actelion Pharmaceuticals Ltd Lactam derivatives useful as orexin receptor antagonists
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
AR084308A1 (es) 2010-12-17 2013-05-08 Syngenta Participations Ag Compuestos insecticidas derivados de triazol
EP2592154A1 (en) * 2011-11-09 2013-05-15 Cellzome Ag Immobilization products and methods for the identification of histone demethylase interacting molecules and for the purification of histone demethylase proteins
US9604961B2 (en) 2012-12-06 2017-03-28 Celgene Quanticel Research, Inc. Histone demethylase inhibitors

Similar Documents

Publication Publication Date Title
JP2016501882A5 (enExample)
JP2016514159A5 (enExample)
JP2016503809A5 (enExample)
JP2016503799A5 (enExample)
JP2017519781A5 (enExample)
JP2017527590A5 (enExample)
JP2013537203A5 (enExample)
JP2016518328A5 (enExample)
JP2009263394A5 (enExample)
JP2012140436A5 (ja) 物質
JP2017524735A5 (enExample)
JP2016501250A5 (enExample)
JP2016501221A5 (enExample)
JP2013542218A5 (enExample)
JP2016521119A5 (enExample)
JP2013079282A5 (enExample)
JP2015520140A5 (enExample)
JP2016533366A5 (enExample)
JP2016515561A5 (enExample)
JP2012092103A5 (enExample)
JP2016506935A5 (enExample)
JP2012512863A5 (enExample)
JP2016531126A5 (enExample)
EA201491820A1 (ru) Новые тиенопиримидиновые производные, способы их получения и их терапевтические применения
JO3263B1 (ar) مشتق إندان سلفاميد جديد